Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Montserrat

Showing results (1-10 of 419) with videos related to

Pageof 42
Sort By:
Medicina Clinica|December 1, 1990
[The treatment of non-Hodgkin's lymphomas]E Montserrat
Current Opinion in Oncology|January 1, 1997
Chronic lymphoproliferative disordersE Montserrat
Annals of Hematology|January 5, 2002
Prognostic factors in aggressive lymphoma: the contribution of novel biological markersE Montserrat
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2004
Assessing prognosis in patients with chronic lymphocytic leukemia a quarter of a century after Rai and Binet staging systemsE Montserrat
Hematology and Cell Therapy|October 19, 2000
Current therapy for CLLE Montserrat
Hematology and Cell Therapy|February 21, 1998
New therapeutic issues in CLLE Montserrat
Medicina Clinica|January 21, 1995
[The never ending story]E Montserrat
Sangre|January 1, 1977
[Some contributions of immunology to the study of lymphoproliferative syndromes (author's transl)]E Montserrat-Costa
Bone Marrow Transplantation|March 2, 2016
Transplantation in CLL: what we can learn from a dinosaurP Dreger, E Montserrat
Drugs|January 1, 1994
Current approaches to the treatment and management of chronic lymphocytic leukaemiaE Montserrat, C Rozman
Pageof 42

Showing results (1-10 of 419) with videos related to

Sort By:
Pageof 42
Medicina Clinica|December 1, 1990
[The treatment of non-Hodgkin's lymphomas]E Montserrat
Current Opinion in Oncology|January 1, 1997
Chronic lymphoproliferative disordersE Montserrat
Annals of Hematology|January 5, 2002
Prognostic factors in aggressive lymphoma: the contribution of novel biological markersE Montserrat
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2004
Assessing prognosis in patients with chronic lymphocytic leukemia a quarter of a century after Rai and Binet staging systemsE Montserrat
Hematology and Cell Therapy|October 19, 2000
Current therapy for CLLE Montserrat
Hematology and Cell Therapy|February 21, 1998
New therapeutic issues in CLLE Montserrat
Medicina Clinica|January 21, 1995
[The never ending story]E Montserrat
Sangre|January 1, 1977
[Some contributions of immunology to the study of lymphoproliferative syndromes (author's transl)]E Montserrat-Costa
Bone Marrow Transplantation|March 2, 2016
Transplantation in CLL: what we can learn from a dinosaurP Dreger, E Montserrat
Drugs|January 1, 1994
Current approaches to the treatment and management of chronic lymphocytic leukaemiaE Montserrat, C Rozman
Pageof 42